Invention Application
US20130210814A1 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
有权
环烷基取代的嘧啶二胺化合物及其用途
- Patent Title: Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
- Patent Title (中): 环烷基取代的嘧啶二胺化合物及其用途
-
Application No.: US13757262Application Date: 2013-02-01
-
Publication No.: US20130210814A1Publication Date: 2013-08-15
- Inventor: Hui Li , Ankush Argade , Rajinder Singh , Sambaiah Thota , David Carroll , Kin Tso , Vanessa Taylor , John McLaughlin , Vadim Markovtsov
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07D401/12 ; C07D471/08 ; C07D295/155 ; C07D403/12 ; C07D417/12 ; C07D413/12
Abstract:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Public/Granted literature
- US09725419B2 Cycloalkyl substituted pyrimidinediamine compounds and their uses Public/Granted day:2017-08-08
Information query
